Avient CDP Climate Change Questionnaire 2022 Friday, July 29, 2022 4 Row 1 Bulk organic chemicals Bulk inorganic chemicals Other chemicals Other, please specify Polymer Compounding C0.8 (C0.8) Does your organization have an ISIN code or another unique identifier (e.g., Ticker, CUSIP, etc.)? The Board would also periodically consider the Company’s 4 P’s of Sustainability: • People: Review matters related to corporate culture – workforce of the future, succession planning, talent reviews, safety, diversity and inclusion, community service, and ethics and transparency For example, in 2021, we entered into a VPPA in Europe that will produce 37.5 MW of Avient CDP Climate Change Questionnaire 2022 Friday, July 29, 2022 19 solar energy with benefits beginning in 2023.

4.

4.

Drying non-halogenated materials is suggested. 2 hours @ 100 (38) Moisture Range (%) Not required

在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

Steel – Static 0.25 0.46 0.18 0.15 0.12 0.19 0.11 0.14 0.13 0.24 0.17 0.17 Impact Notched Izod Impact (23°C, 3.18 mm, Injection Molded) J/m ASTM D256A 41 64(6) 110 107 107 70 80 37 37 75 – 69 Thermal Properties Heat Deflection Temperature ASTM D648 0.45 MPa °C 215(6) – 250 215 216 184 152 151(6) 153(6) 218(6) – – 1.8 MPa °C 65(6) 239(7) 244(6) 210 210 75 94 81.1(6) 88 197(6) – 135(5) Electrical Properties Surface Resistivity ohms/sq ASTM D254 – – – 1.30x1012 1.9x1012 5.2x1012 – – – – – 1.0x109 Dielectric Strength (Short Time) kV/mm – – 8.5 – – – – – – – – – Flammability Flame Rating Class UL 94 HB – – HB HB HB – HB – – – – LubriOne™ Internally Lubricated Formulations NOTES (1) Type I, 5.1mm/min (2) Type I, 21.3 mm/min (3) Type I, 50 mm/min (4) Type I, 5.1mm/min, Break (5) 3.2 mm thick, Unannealed (6) 6.35 mm thick, Unannealed (7) 3.2 mm thick, Annealed PRODUCT DESCRIPTION UNITS TEST METHOD 5024 RS HI 5021 RS S1 5021 RS X2 5019 X1 LB6700- 5001 RS AF Black NN- 000/01M Black SO REC LB6600- 5030 RS Grey LB3300- 5010 RS LB3300- 5005 RS REC LB3220- 5001 RS C Natural X1 5010 GP Grey 5006 RS PE 5004 RS PE LB4200- 5022 Black LB4200- 5023 Base Polymer PA 6 PA6/PA66 PA66 PBT PC PKE POM Lubricant UHMWPE1 UHMWPE UHMWPE UHMWPE UHMWPE MoS22 Graphite UHMWPE UHMWPE UHMWPE Graphite UHMWPE UHMWPE MoS2 UHMWPE Filler type GF10 GF30 GF30 GF50 GF50 Unfilled GF33 GF20 MI20 GF10 Unfilled GF20 GF30 Unfilled Unfilled General Properties Specific Gravity g/cm3 ISO 1183 1.18 1.35 1.39 1.55 1.58 1.14 1.44 1.42 1.46 1.23 1.26 1.34 1.43 1.4 1.35 Mechanical Properties Tensile Modulus (23°C) MPa ISO 527-1 4250 9500 9000 15500 16600 3500 10600 6300 3330 4000 1630 5300 9250 2470 2150 Tensile Strength (Yield, 23°C) MPa ISO-527-2 97 150 160 205 200 85 164 102 55 60 60 108 99.1 55 50 Tensile Elongation (Break, 23°C) % ISO-527-2 12 2.5 3 2.7 2.4 3.4 2.0 4.2 8 2.5 46 3.7 1.5 11 11 Flexural Strength (23°C) MPa ISO 178 103 – – 285 265 108 215 127 78 85 38 155 117 73 68 Flexural Modulus (23°C) MPa ISO 178 3250 – – 12400 11100 2690 9000 4700 3000 3100 1380 4600 5450 2210 2070 Impact Charpy Notched Impact Strength (23°C, Injection Molded) kJ/m^2 ISO 179 14 12 10 15 10 3 6 7.7 4.3 12 15 10 7.6 8 5 Charpy Unnotched Impact Strength (23°C, Injection Molded) kJ/m^2 ISO 179 82 55 61 75 60 65 50 47 69 - NB 63 36 NB NB Thermal Properties Deflection Temperature Under Load 1.8 Mpa, Unannealed °C ISO 75-2/A 107 – – 204 – 73 235 – – – 90 210 204 86 80 Cofficient of Friction (CoF) & Wear Rate CoF vs.

在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s 4 annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings.

With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation

Feb 10, 2025